Skip to content

Apotheek M. PEETERS

Active
Private limited companyfounded 1970active for 55 yearsDorpsstraat 39, 3720 Hasselt, BelgiumKBO/BCE: BE 0407.815.318

From the official registers: KBO 48 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Apotheek M. PEETERS has been active since 1970 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €880,798 and a net result of €122,648. Equity has been growing by about 18% per year since 2019. Its solvency ranks better than 92% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
Apotheek M. PEETERSActiveChecked score 98/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 27-12-1970 Normal situation
Legal form
Private limited company
Registered office
Dorpsstraat 39, 3720 Hasselt
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.005.624.359 3720 Hasselt, since 01-02-1971
Financial year end
30 June
Peppol
Reachable since 19-01-2026
Company details

Board and ownership

Board
Shareholders
Board & ownership

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-06-2025
Gross margin
€292,059
▲ 19.4%
Turnover
≈ €1.1m
estimated
Profit
€122,648
▲ 45.9%
Equity
€880,798
▲ 16.2%
Total assets
€1.0m
▲ 1.3%
Staff
1.8 FTE
▼ 10.0%
2025 accounts filed 1 day before the deadline
Filed on 30-01-2026PDF
Financials
Score breakdownlowers riskLiquidity: current ratio 6.43, cash €364,219Founded in 1970Equity €880,798 (84.6% of total assets)Size: 1.8 FTE, total assets €1.0mShow the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 83% of micro companies in retail trade (NACE 47)
Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Strong
Solvency 100+1
equity 84.6% of total assets
Liquidity 92+17
short-term debt 13.4% · cash 35.0%
Profitability 83+4
return on assets 11.8%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: 0.1%▲ +0.1 percentage points vs 01-2026highest value 03-2026: < 0.1%▼ -0.1 percentage points vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €85,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.43 (4.03 in 2024), above the usual 1.5. Short-term debt is 13.4% and cash 35% of total assets. 15.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 92% on liquidity, 77% on profitability and 69% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 6.43, cash €364,219
NBB · annual accounts
lowers risk · Founded in 1970
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Equity €880,798 (84.6% of total assets)
NBB · annual accounts
lowers risk · Size: 1.8 FTE, total assets €1.0m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
1 day early
2024
on the day
2023
1 day early
2022
on the day
2021
on the day
2020
2 days early
2019
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 1 day before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 31 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end01-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 92% of companies in retail tradesector median 36.6% · 12,757 companies 84.6% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €122,648 7 years View

Documents

Annual accounts at the NBB

All 48 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Apotheek M. PEETERS

What is the company number of Apotheek M. PEETERS?
The company number of Apotheek M. PEETERS is 0407.815.318. The VAT number is the same number with BE in front: BE 0407.815.318.
Where is Apotheek M. PEETERS based?
The registered office is at Dorpsstraat 39, 3720 Hasselt.Company details
What does Apotheek M. PEETERS do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek M. PEETERS?
The legal form of Apotheek M. PEETERS is Private limited company (BV).
When was Apotheek M. PEETERS founded?
Apotheek M. PEETERS was founded on 27-12-1970.
Is Apotheek M. PEETERS still active?
Yes, Apotheek M. PEETERS is an active enterprise in the KBO register.
How many employees does Apotheek M. PEETERS have?
Apotheek M. PEETERS had an average of 1.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek M. PEETERS?
The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €292,059 and 47 comparable companies (NACE 477). It probably lies between €830,000 and €1.7m.
Is Apotheek M. PEETERS profitable?
In financial year 2025, Apotheek M. PEETERS made a profit of €122,648.
Where can I find the annual accounts of Apotheek M. PEETERS?
Apotheek M. PEETERS filed 48 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Apotheek M. PEETERS due?
Apotheek M. PEETERS must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Companies linked to Apotheek M. PEETERS

Comparable companies

These companies have the same main activity as Apotheek M. PEETERS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €902,000 and €1.2m, founded between 1971 and 1986.

CompanyTotal assetsGross margin
Apotheek M. PEETERS Hasselt€1.0m€0.3m
APOTHEEK KUYKENS Kasterlee€1.1m€0.3m
APOTHEEK PAESEN Maaseik€1.1m€0.3m
Apotheek Clessens Antwerpen€1.2m€0.3m
PHARMAYOU GLONS Bassenge€0.9m€0.4m
Apotheek Stas-Coertjens Hasselt€1.0m€0.3m
LANGENAKEN Bilzen-Hoeselt€1.2m€0.3m
Full comparison

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure